(decided that a new thread was needed - please keep the discussion on-topic)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751723/pdf/ott-13-12845.pdf
(just some of the many interesting figures)
Orange text = relevant to RAC 3-pillar strategy (although not necessarily under Pillar 1 - FTO)
Role of FTO in Breast Cancer
Role of FTO in Leukaemia
Role of FTO in Clear Cell Renal Cell Carcinoma (at right) and Bladder Cancer (at left)
Role of FTO in Ovarian Cancer (at left of figure), Endometrial Cancer and Cervical Squamous Cell Carcinoma
-
- There are more pages in this discussion • 3,055 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
-0.025(2.07%) |
Mkt cap ! $205.8M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.16 | $184.2K | 156.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7199 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 1204 | 1 |
View Market Depth
| Last trade - 16.18pm 03/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |